Chlorzoxazone
- Product NDC
- 0254-2053
- 11-digit product format
- 002542053
- Labeler code
- 0254
- Product ID
- 0254-2053_fdae58ba-f86a-47bc-af18-a80d5cfa1107
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlorzoxazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Endo USA, Inc.
- Application
- ANDA212743
- Marketing category
- ANDA
- Marketing start
- 2021-06-17
- Substance
- CHLORZOXAZONE
- Active strength
- 375 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Chlorzoxazone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORZOXAZONE | 375 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | H0DE420U8G |
| Rxcui | 1088934, 1088936 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0254-2053-01 | Chlorzoxazone | 100 in 1 BOTTLE | TABLET | 100 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0254-2053 | CHLORZOXAZONE TABLET [ENDO USA, INC.] | 12 | Current NDC, Legacy NDC, 1 package rows | 20250112_7c5a835d-3754-4c25-a0e2-335b8eceb2d2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0254-2053-01 | 00254205301 | 100 TABLET in 1 BOTTLE (0254-2053-01) | 100 tablet | 2021-06-17 | 0000-00-00 | No | No | Current |